Repligen Corporation

NasdaqGS:RGEN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 7.00 B

Share Price

USD 124.34

Avg Daily Volume

832,454

Change (1 day)

-1.81%

Change (1 year)

-23.53%

Change (YTD)

-13.61%

Repligen Corporation Accounts Payable for the year ending December 31, 2024: USD 32.13 M

Repligen Corporation Accounts Payable is USD 32.13 M for the year ending December 31, 2024, a 64.26% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Repligen Corporation Accounts Payable for the year ending December 31, 2023 was USD 19.56 M, a -29.00% change year over year.
Repligen Corporation Accounts Payable for the year ending December 31, 2022 was USD 27.55 M, a -23.89% change year over year.
Repligen Corporation Accounts Payable for the year ending December 31, 2021 was USD 36.20 M, a 114.47% change year over year.
Repligen Corporation Accounts Payable for the year ending December 31, 2020 was USD 16.88 M, a 47.75% change year over year.